A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A
- PMID: 1370175
- DOI: 10.1093/infdis/165.1.53
A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A
Abstract
Serogroup A Neisseria meningitidis of subgroup III has caused two pandemics of meningococcal meningitis since 1966 and recently spread to East Africa. The last epidemics in West Africa in the early 1980s were caused by clone IV-1. Surface antigens of clone IV-1 strains from West Africa and subgroup III strains from both pandemic waves were analyzed. Lipopolysaccharide was stable within clone IV-1 but variable in subgroup III. Pili from clone IV-1 possessed class I epitopes, while those from subgroup III also possessed class IIa epitopes. Certain class 5 protein variants were expressed by both bacterial clones, possibly reflecting either inheritance of primeval genes or horizontal transmission. Exposure of Gambians to clone IV-1 bacteria stimulated production of bactericidal antibodies cross-reactive with subgroup III bacteria in some individuals but of type-specific antibodies in others. Gambians without bactericidal antibodies usually became healthy carriers rather than developing meningococcal disease on exposure to virulent meningococci.
Similar articles
-
Clonal and variable properties of Neisseria meningitidis isolated from cases and carriers during and after an epidemic in The Gambia, West Africa.J Infect Dis. 1989 Apr;159(4):686-700. doi: 10.1093/infdis/159.4.686. J Infect Dis. 1989. PMID: 2494268
-
Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94.Epidemiol Infect. 1996 Apr;116(2):115-20. doi: 10.1017/s095026880005233x. Epidemiol Infect. 1996. PMID: 8620901 Free PMC article.
-
Epidemic spread and antigenic variability of Neisseria meningitidis.Trends Microbiol. 1995 May;3(5):186-92. doi: 10.1016/s0966-842x(00)88918-0. Trends Microbiol. 1995. PMID: 7627456 Review.
-
Antibodies against IgA1 protease are stimulated both by clinical disease and asymptomatic carriage of serogroup A Neisseria meningitidis.J Infect Dis. 1992 Dec;166(6):1316-21. doi: 10.1093/infdis/166.6.1316. J Infect Dis. 1992. PMID: 1431249
-
Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.Rev Infect Dis. 1985 Jul-Aug;7(4):504-10. doi: 10.1093/clinids/7.4.504. Rev Infect Dis. 1985. PMID: 2412271 Review.
Cited by
-
Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989.J Clin Microbiol. 2006 Mar;44(3):861-71. doi: 10.1128/JCM.44.3.861-871.2006. J Clin Microbiol. 2006. PMID: 16517868 Free PMC article.
-
Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis.Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5234-9. doi: 10.1073/pnas.061386098. Epub 2001 Apr 3. Proc Natl Acad Sci U S A. 2001. PMID: 11287631 Free PMC article.
-
Production and characterization of monoclonal antibodies to type 8 lipooligosaccharide of Neisseria meningitidis.J Clin Microbiol. 1992 Aug;30(8):2047-53. doi: 10.1128/jcm.30.8.2047-2053.1992. J Clin Microbiol. 1992. PMID: 1380009 Free PMC article.
-
Functional activities and immunoglobulin variable regions of human and murine monoclonal antibodies specific for the P1.7 PorA protein loop of Neisseria meningitidis.Infect Immun. 2000 Apr;68(4):1871-8. doi: 10.1128/IAI.68.4.1871-1878.2000. Infect Immun. 2000. PMID: 10722576 Free PMC article.
-
Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugates.Infect Immun. 1993 May;61(5):1873-80. doi: 10.1128/iai.61.5.1873-1880.1993. Infect Immun. 1993. PMID: 8478076 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources